<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2410" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39035636</article-id><article-id pub-id-type="pmc">PMC11258462</article-id>
<article-id pub-id-type="doi">10.1002/deo2.410</article-id><article-id pub-id-type="publisher-id">DEO2410</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The influence of color vision deficiency on vessel visibility during colorectal endoscopic submucosal dissection and the potential advantage of red dichromatic imaging to achieve color vision barrier&#x02010;free</article-title><alt-title alt-title-type="left-running-head">OHNO <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2410-cr-0001" contrib-type="author"><name><surname>Ohno</surname><given-names>Akiko</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2271-5141</contrib-id><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0002" contrib-type="author"><name><surname>Miyamoto</surname><given-names>Naohiko</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0003" contrib-type="author"><name><surname>Kaji</surname><given-names>Ryosuke</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0004" contrib-type="author"><name><surname>Shirakawa</surname><given-names>Takahiro</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0005" contrib-type="author"><name><surname>Watanabe</surname><given-names>Moegi</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0006" contrib-type="author"><name><surname>Sumi</surname><given-names>Ryutaro</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0007" contrib-type="author"><name><surname>Jinbo</surname><given-names>Yoko</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0008" contrib-type="author"><name><surname>Kusuhara</surname><given-names>Mitsunori</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2410-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2410-cr-0009" contrib-type="author"><name><surname>Miyoshi</surname><given-names>Jun</given-names></name><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2410-cr-0010" contrib-type="author" corresp="yes"><name><surname>Hisamatsu</surname><given-names>Tadakazu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1178-3536</contrib-id><xref rid="deo2410-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>thisamatsu@ks.kyorin-u.ac.jp</email></address></contrib></contrib-group><aff id="deo2410-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology and Hepatology</named-content>
<institution>Kyorin University School of Medicine</institution>
<named-content content-type="country-part">Tokyo</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo2410-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Endoscopy Division</named-content>
<institution>National Cancer Center Hospital</institution>
<named-content content-type="country-part">Tokyo</named-content>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Tadakazu Hisamatsu, Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, 6&#x02010;20&#x02010;2 Shinkawa, Mitaka, Tokyo 181&#x02013;8611, Japan.<break/> Email: <email>thisamatsu@ks.kyorin-u.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="106">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e410</elocation-id><history>
<date date-type="rev-recd"><day>27</day><month>6</month><year>2024</year></date>
<date date-type="received"><day>23</day><month>3</month><year>2024</year></date>
<date date-type="accepted"><day>30</day><month>6</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e410.pdf"/><abstract><title>Abstract</title><sec id="deo2410-sec-0010"><title>Objectives</title><p>Although color information is important in gastrointestinal endoscopy, there are limited studies on how endoscopic images are viewed by people with color vision deficiency. We aimed to investigate the differences in the visibility of blood vessels during endoscopic submucosal dissection (ESD) among people with different color vision characteristics and to examine the effect of red dichromatic imaging (RDI) on blood vessel visibility.</p></sec><sec id="deo2410-sec-0020"><title>Methods</title><p>Seventy&#x02010;seven pairs of endoscopic images of white light imaging (WLI) and RDI of the same site were obtained during colorectal ESD. The original images were set as type C (WLI&#x02010;C and RDI&#x02010;C), a common color vision. These images were computationally converted to simulate images perceived by people with color vision deficiency protanope (Type P) or deutanope (Type D) and denoted as WLI&#x02010;P and RDI&#x02010;P or WLI&#x02010;D and RDI&#x02010;D. Blood vessels and background submucosa that needed to be identified during ESD were selected in each image, and the color differences between these two objects were measured using the color difference (&#x00394;<italic toggle="yes">E</italic>
<sub>00</sub>) to assess the visibility of blood vessels.</p></sec><sec id="deo2410-sec-0030"><title>Results</title><p>&#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between a blood vessel and the submucosa was greater under RDI (RDI&#x02010;C/P/D: 24.05 &#x000b1; 0.64/22.85 &#x000b1; 0.66/22.61 &#x000b1; 0.64) than under WLI (WLI&#x02010;C/P/D: 22.26 &#x000b1; 0.60/5.19 &#x000b1; 0.30/8.62 &#x000b1; 0.42), regardless of color vision characteristics. This improvement was more pronounced in Type P and Type D and approached Type C in RDI.</p></sec><sec id="deo2410-sec-0040"><title>Conclusions</title><p>Color vision characteristics affect the visibility of blood vessels during ESD, and RDI improves blood vessel visibility regardless of color vision characteristics.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2410-kwd-0001">colorectal neoplasms</kwd><kwd id="deo2410-kwd-0002">color vision deficiency</kwd><kwd id="deo2410-kwd-0003">diversity</kwd><kwd id="deo2410-kwd-0004">endoscopic submucosal dissection</kwd><kwd id="deo2410-kwd-0005">universal design</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Olympus Corporation
</institution><institution-id institution-id-type="doi">10.13039/100009734</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="7"/><word-count count="4031"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="deo2410-note-0001"><p>For this research, we borrowed the equipment necessary for image capture during ESD from Olympus Corporation. (<ext-link xlink:href="https://www.olympus-global.com/" ext-link-type="uri">https://www.olympus&#x02010;global.com/</ext-link>).</p></fn></fn-group></notes></front><body><sec id="deo2410-sec-0050"><title>INTRODUCTION</title><p>Color vision deficiency (CVD) is a condition in which different colors are difficult to distinguish. CVD affects as many as 8% of males and 0.4% of females.<xref rid="deo2410-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> The difference in prevalence between males and females reflects the fact that the commonest forms of congenital CVD are inherited in an X&#x02010;linked recessive manner.<xref rid="deo2410-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> CVD is divided into protanope, deuteranope, and tritanope, and color appearance differs depending on which cones are abnormal.</p><p>In modern society, advances in electronic technologies have led to the widespread use of designs with many colors. In Japan, an awareness campaign initiated by congenital CVD people started around 2000, and efforts have since been made to color designs for universal visibility.<xref rid="deo2410-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> However, there has been scarce evaluation of image visibility in the medical field, particularly for endoscopists with CVD.</p><p>Many doctors with CVD are likely unaware of their vision characteristics. In a study investigating the frequency of CVD among 120 medical students, 5.83% were color&#x02010;weak, and among the color&#x02010;deficient students, 57.0% were protanopic while 43.0% were deuteranopic.<xref rid="deo2410-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> A study examining the prevalence of CVD in medical and dental students compared with non&#x02010;medical students found no differences between the two groups.<xref rid="deo2410-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Additionally, a study from the Netherlands reported that 8% of gastrointestinal endoscopists were diagnosed with CVD.<xref rid="deo2410-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> This study indicates that CVD does not affect the accuracy of endoscopic diagnosis. To our knowledge, this is the only study investigating CVD and endoscopic diagnosis ability. However, given that color is one of the important information in gastrointestinal endoscopy and a certain percentage of endoscopists have CVD from an epidemiological viewpoint, understanding the effect of CVD on endoscopic medicine and devising improvement measures, if needed, will be beneficial for best practice.</p><p>Endoscopic submucosal dissection (ESD) is a therapeutic procedure for gastrointestinal tumors and is widely practiced worldwide.<xref rid="deo2410-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> During ESD, it is critical for endoscopists to visually check the blood vessels running through the submucosa before proceeding with the dissection to prevent bleeding.<xref rid="deo2410-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> We found that a trainee preferred a type of image enhancement endoscopy (IEE), namely red dichromatic imaging (RDI), rather than regular white light imaging (WLI) to identify blood vessels during colon ESD. These findings raised clinical questions of whether (1) CVD would affect the visibility of blood vessels during ESD and (2) RDI could improve the visibility of blood vessels during the procedure regardless of color vision characteristics.</p><p>IEE is an observation method that converts the wavelength of light in WLI to emphasize the patterns on the mucosal surface of the gastrointestinal tract, the contours of blood vessels, and the color tone.<xref rid="deo2410-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> RDI is one of the new IEE methods that uses three types of light (red, amber, and green) with different characteristics to create deep tissue contrast.<xref rid="deo2410-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> There are three types of RDI modes, each of which produces a characteristic image. Under the basic mode, RDI mode 1, deep blood vessels are depicted in orange for individuals without CVD. In ESD, submucosa injected with indigo carmine appears more vividly blue under RDI than under white light.<xref rid="deo2410-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> Blood vessels in the submucosa are depicted in orange for arteries and red for veins owing to the difference in oxygen saturation. Eventually, the visibility of blood vessels improves, and arteries and veins can be distinguished. Some studies suggest that RDI improves the visibility of blood vessels and bleeding points and shortens the hemostasis time during colon ESD.<xref rid="deo2410-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo2410-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> However, the effect of RDI on endoscopists with and without CVD has not been investigated so far.</p><p>Today various computational tools are employed to contribute to progressing universal color designs. One such computer&#x02010;based tool is the CVD calibration function within Adobe Illustrator (<ext-link xlink:href="http://www.adobe.com" ext-link-type="uri">http://www.adobe.com</ext-link>), which can simulate and display images perceived by people with protanope (Type P) and deuteranope (Type D). Such tools are used in the medical field to simulate visibility for pathologists and ophthalmologists with CVD.<xref rid="deo2410-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo2410-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Our study aimed to use this computational simulation to investigate how the visibility of submucosal vessels during colorectal ESD procedures varies among people with different color vision characteristics and to examine whether RDI contributes to improving visibility for people with each of the investigated color vision characteristics.</p></sec><sec id="deo2410-sec-0060"><title>PATIENTS/MATERIAL AND METHODS</title><sec id="deo2410-sec-0070"><title>Study design</title><p>The clinical database of Kyorin University Hospital was used for this retrospective study. From April 2021 to March 2023, colorectal ESD was performed on 90 patients with early colorectal cancer, adenomatous lesions, sessile serrated lesions, or neuroendocrine tumors at Kyorin University Hospital. Among these patients, 18 patients had WLI and RDI mode 1 endoscopic images of the same site, which were taken during colorectal ESD (Table&#x000a0;<xref rid="deo2410-tbl-0001" ref-type="table">1</xref>). ESD of the 18 patients was performed consecutively within the study period, using the EVIS X1 endoscopic system equipped with a PCF&#x02010;H290TI endoscope (Olympus, Tokyo, Japan). In these cases, a total of 77 pairs of WLI and RDI endoscopic images were analyzed. The images in each case were anonymized and arranged in the order in which they could have been taken using WLI and RDI in the same scene. The image of the submucosa had at least one blood vessel that the endoscopist should notice. A blood vessel that needs to be identified and distinguished during ESD was selected in each image. Two points on the blood vessel and two points on the background submucosa next to each point on the blood vessel (i.e., two pairs in each image, 154 positions in total) were designated to measure the color difference using &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub>. We set each region of interest as a 5&#x02010;pixel square on Adobe Photoshop (<ext-link xlink:href="http://www.adobe.com" ext-link-type="uri">http://www.adobe.com</ext-link>) to assess &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub>. &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> is a color difference calculated using the color difference formula CIEDE2000,<xref rid="deo2410-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> which was expressed by the CIE (Commission Internationale de l'Eclairage) in 1976 as the distance between two points in the L*a*b* color space and has been improved subsequently. The analysts were Dr. Ohno and Dr. Miyoshi and they were blinded to the clinical demographics of cases when analyzing the data.</p><table-wrap position="float" id="deo2410-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Clinical demographics of cases with endoscopic submucosal dissection.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Case</th><th align="left" rowspan="1" colspan="1">Age</th><th align="left" rowspan="1" colspan="1">Sex</th><th align="left" rowspan="1" colspan="1">Location</th><th align="left" rowspan="1" colspan="1">Lesion size (mm)</th><th align="left" rowspan="1" colspan="1">Procedure time (min)</th><th align="left" rowspan="1" colspan="1">Pathology</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">81</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">111</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">Tubulovillous adenoma</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">77</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">Tubulovillous adenoma</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">Rb</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">125</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">86</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">Sessile serrated lesion</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">RS</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Ra</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">Tubulovillous adenoma</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">84</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">RS</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">Sessile serrated lesion</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Rb</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">Neuroendocrine tumor G1</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">Sessile serrated lesion</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">Tubular adenocaecinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">Rb</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">Neuroendocrine tumor G1</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">Tubular adenocarcinoma</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">Tubulovillous adenoma</td></tr></tbody></table><table-wrap-foot><fn id="deo2410-tbl1-note-0001"><p>Abbreviations: A, ascending colon; C, cecum; Ra, rectum above the peritoneal reflection; Rb, rectum below the peritoneal reflection; RS, rectosigmoid junction; S, sigmoid colon; T, transverse colon.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2410-sec-0080"><title>Endoscopic images simulating CVD</title><p>The recorded WLI and RDI mode1 images were converted to images perceived by people with CVD Type P or D using the color blindness simulation tool built into Adobe Illustrator (Figures&#x000a0;<xref rid="deo2410-fig-0001" ref-type="fig">1</xref> and&#x000a0;<xref rid="deo2410-fig-0002" ref-type="fig">2</xref>). The pre&#x02010;conversion images were denoted as WLI&#x02010;C and RDI&#x02010;C to reflect the observations of people with common color vision, Type C. The post&#x02010;conversion images were assigned suffixes P (i.e., WLI&#x02010;P and RDI&#x02010;P) or D (i.e., WLI&#x02010;D and RDI&#x02010;D) to reflect the observations of people with CVD Type P or D, respectively.</p><fig position="float" fig-type="FIGURE" id="deo2410-fig-0001"><label>FIGURE 1</label><caption><p>Original white light images obtained during endoscopic submucosal dissection were computationally converted to images simulating vision with color vision deficiency. A representative white light image obtained during endoscopic submucosal dissection and computationally converted images simulating vision with color vision deficiency Types C and D are shown. Blood vessels that appear red in Type C (yellow arrowheads) are depicted darker in Types P and D. Two points on the blood vessel and two points on the background submucosa are shown in the enlarged figure.</p></caption><graphic xlink:href="DEO2-5-e410-g004" position="anchor" id="jats-graphic-1"/></fig><fig position="float" fig-type="FIGURE" id="deo2410-fig-0002"><label>FIGURE 2</label><caption><p>Original images obtained with red dichromatic imaging mode 1 during endoscopic submucosal dissection were computationally converted to images simulating vision with color vision deficiency. A representative image obtained with red dichromatic imaging mode 1 during endoscopic submucosal dissection and computationally converted images simulating vision with color vision deficiency Types C and D are shown. Blood vessels appear yellow in all color vision types (red arrowheads). Two points on the blood vessel and two points on the background submucosa are shown in the enlarged figure.</p></caption><graphic xlink:href="DEO2-5-e410-g003" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="deo2410-sec-0090"><title>Outcomes</title><p>The primary endpoint was to assess &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between WLI and RDI images in each group of color vision types (C, P, and D). The secondary endpoint was to compare &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between WLI and RDI among the groups of color vision types.</p></sec><sec id="deo2410-sec-0100"><title>Statistical analysis</title><p>Wilcoxon matched&#x02010;pairs signed rank test was performed to compare &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between WLI and RDI in each group of color vision types (C, P, and D). We used the Friedman test and Dunn's multiple comparisons test to compare color differences between WLI and RDI images among the three groups of color vision types. The criterion of statistical significance was set at <italic toggle="yes">p</italic> &#x0003c; 0.05. IBM SPSS Statistics (ver. 24; IBM) and GraphPad Prism (ver.9.5.1; GraphPad Software) were used for statistical analyses.</p></sec></sec><sec id="deo2410-sec-0110"><title>ETHICS STATEMENT</title><p>This retrospective study was performed in accordance with the guidelines of the Declaration of Helsinki. This study was approved by the Institutional Review Board of Kyorin University School of Medicine (IRB No. 36) on April 4, 2022. Informed consent was obtained using an opt&#x02010;out method.</p></sec><sec id="deo2410-sec-0120"><title>RESULTS</title><sec id="deo2410-sec-0130"><title>RDI increases the color difference between a blood vessel and the submucosa regardless of color vision characteristics</title><p>The &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between a blood vessel and the background submucosa was evaluated as an indicator of the visibility of the blood vessel. In the Type C group, &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> was 22.26 &#x000b1; 0.60 (mean &#x000b1; SEM) under WLI (WLI&#x02010;C) and 24.05 &#x000b1; 0.64 under RDI (RDI&#x02010;C). Therefore, &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> was significantly larger in RDI&#x02010;C images than in WLI&#x02010;C images (<italic toggle="yes">p</italic> = 0.0035; Figure&#x000a0;<xref rid="deo2410-fig-0003" ref-type="fig">3a</xref>). In the Type P group, &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> was 5.19 &#x000b1; 0.30 under WLI (WLI&#x02010;P) and 22.85 &#x000b1; 0.66 under RDI (RDI&#x02010;P). Therefore, &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> was significantly larger in RDI&#x02010;P images than in WLI images (<italic toggle="yes">p</italic> &#x0003c; 0.0001; Figure&#x000a0;<xref rid="deo2410-fig-0003" ref-type="fig">3b</xref>). In the Type D group, &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> was 8.62 &#x000b1; 0.42 under WLI (WLI&#x02010;D) and was 22.61 &#x000b1; 0.64 under RDI (RDI&#x02010;D). Therefore, &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> was significantly larger in RDI&#x02010;D images than in WLI&#x02010;D images (<italic toggle="yes">p</italic> &#x0003c; 0.0001; Figure&#x000a0;<xref rid="deo2410-fig-0003" ref-type="fig">3c</xref>). Overall, these findings indicated that RDI has the potential to improve the visibility of blood vessels regardless of color vision characteristics, and the improvement is more prominent in the CVD groups (Types P and D) than in the Type C group.</p><fig position="float" fig-type="FIGURE" id="deo2410-fig-0003"><label>FIGURE 3</label><caption><p>Color difference between a blood vessel and the submucosa in each color vision characteristic. The color differences (&#x00394;<italic toggle="yes">E</italic>
<sub>00</sub>) between a blood vessel and the submucosa were measured at two positions in each image of white light imaging (WLI) and red dichromatic imaging. Original images representing Type C (a) and converted images simulating Types P (b) and D (c) were analyzed (<italic toggle="yes">n</italic> = 154 in each group). **<italic toggle="yes">p</italic> &#x0003c; 0.01 and ****<italic toggle="yes">p</italic> &#x0003c; 0.0001 with Wilcoxon matched&#x02010;pairs signed rank test.</p></caption><graphic xlink:href="DEO2-5-e410-g002" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="deo2410-sec-0140"><title>RDI decreased the gap in the color difference between color vision characteristics</title><p>Under WLI, the &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> of Types C, P, and D were 22.26 &#x000b1; 0.60, 5.19 &#x000b1; 0.30, and 8.62 &#x000b1; 0.42, respectively (Figure&#x000a0;<xref rid="deo2410-fig-0004" ref-type="fig">4a</xref>). Therefore, the &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> of Type C was significantly larger than that of Types P and D (<italic toggle="yes">p</italic> &#x0003c; 0.0001 for both comparisons). Moreover, the &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> of Type D was significantly larger than that of Type P (<italic toggle="yes">p</italic> &#x0003c; 0.0001). Under RDI, the &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> of Types C, P, and D were 24.05 &#x000b1; 0.64, 22.85 &#x000b1; 0.66, and 22.61 &#x000b1; 0.64, respectively (Figure&#x000a0;<xref rid="deo2410-fig-0004" ref-type="fig">4b</xref>). Therefore, the &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> of Type C was significantly larger than those of Types P (<italic toggle="yes">p</italic> = 0.0365) and D (<italic toggle="yes">p</italic> = 0.0091). There was no significant difference in &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between Types P and D. All L*a*b* values are shown in Figure <xref rid="deo2410-supitem-0001" ref-type="supplementary-material">S1</xref>.</p><fig position="float" fig-type="FIGURE" id="deo2410-fig-0004"><label>FIGURE 4</label><caption><p>Gaps among color vision characteristics in the color difference between a blood vessel and the submucosa under white light imaging and red dichromatic imaging mode. The color differences (&#x00394;<italic toggle="yes">E</italic>
<sub>00</sub>) between a blood vessel and the submucosa under white light image (WLI) (a) and red dichromatic imaging (RDI) (b) were compared among Types C, P, and D. * <italic toggle="yes">p</italic> &#x0003c; 0.05, **<italic toggle="yes">p</italic> &#x0003c; 0.01, and ****<italic toggle="yes">p</italic> &#x0003c; 0.0001 with Dunn's multiple comparison test after the Friedman test.</p></caption><graphic xlink:href="DEO2-5-e410-g001" position="anchor" id="jats-graphic-7"/></fig></sec></sec><sec id="deo2410-sec-0150"><title>DISCUSSION</title><p>Compared with WLI, RDI improved the &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> between a vessel and the submucosa for Types C, P, and D and decreased the difference in &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> among Types C, P, and D. These findings suggest that RDI can contribute to improving the visibility of blood vessels during ESD regardless of color vision characteristics. The results also indicated that RDI during ESD can be beneficial, particularly for endoscopists with Types P and/or D. Improved vascular visibility helps prevent bleeding and contributes to treatment safety. People with Type P CVD see dark red as dark as black. People with Type D CVD have difficulty in seeing green and distinguishing the difference in redness. RDI uses red, amber, and green light with different characteristics to create contrast in deep tissue, with deep blood vessels being represented in orange. Amber is a wavelength of light that is exactly less affected by CVD, so visibility is considered to have improved to the same level as the Type C.</p><p>We should note that this is a computational simulation evaluating &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> as an indicator of the visibility of blood vessels in the submucosa. Our higher brain function is used to recognize objects on the screen during ESD, i.e., we need to understand that color is only one aspect of the information. In this study, through computer simulation, we demonstrated that &#x00394;<italic toggle="yes">E</italic>00 of Types P and D was smaller than Type C. However, this result does not indicate that physicians with Types P and D CVD could experience more difficulty in ESD than those with Type C. Various factors other than blood vessel recognition based on color vision can impact ESD performance and the computer simulation has a limitation in considering these factors. As a future perspective, we plan a study asking individuals with CVD to assess endoscopic images.</p><p>Color vision tests are not required for medical licensing in Japan, as they are in the United States and the United Kingdom.<xref rid="deo2410-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Therefore, given that 80% of Japanese physicians are male<xref rid="deo2410-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> and congenital CVD is more common in males than in females, the prevalence of CVD in Japanese endoscopists may not be low. It is inappropriate to identify an endoscopist's color vision characteristics and link the characteristics to his/her aptitude as an endoscopist. Rather, it is important to recognize that there are endoscopists with various color vision characteristics and to build a system that provides image information to ensure the safety of endoscopic procedures performed by all endoscopists. Furthermore, considering that a certain percentage of medical students and residents have CVD, the concept of universal color design may need to be introduced to learning materials, such as endoscopy atlases and videos. Ron Mace, an advocate of universal design, defines<xref rid="deo2410-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> universal design as &#x0201c;the design of products and environments that can be used by as many people as possible without the need for personal adaptation or special design.&#x0201d; We believe universal design is needed in the endoscopy field.</p><p>While this is the first study on the objective assessment of the visibility of blood vessels and the effect of RDI on visibility among people with CVD, there are several limitations. First, we employed computational simulations and &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub> to assess the visibility of blood vessels during ESD. However, the process by which humans recognize objects is extremely complex, and our method does not reflect this complex process. Further studies with the cooperation of subjects with CVD will be needed to address this point. Nevertheless, the present study demonstrated an ESD method for universal visibility, and this can be a pioneer work in the endoscopic field, providing the scientific basis for future clinical studies. Second, we employed the images of ESD cases performed at our single institution. The concentration of indigo carmine in the local injection used for ESD varies among facilities. Some facilities may use a lower concentration of indigo carmine, leading to a lighter blue color of the submucosa, which would affect the result, specifically &#x00394;<italic toggle="yes">E</italic>
<sub>00</sub>. However, we use common concentrations (0.005%&#x02013;0.01%) of indigo carmine in our practice, and thus our results can have general significance. Finally, there are various degrees of CVD, even in each type. Although the computer&#x02010;based simulation categorizes major CVD types into Types P and D, each individual with Type P or D could perceive color differently. It is very challenging or even impossible to describe how each individual sees and recognizes colors. This is an unavoidable limitation of studies on color vision.</p></sec><sec id="deo2410-sec-0160"><title>CONCLUSION</title><p>Our results indicate that the color vision characteristics of individuals affect the visibility of blood vessels during ESD, and RDI improves blood vessel visibility regardless of color vision characteristics. This study provides new insights for introducing the concept of universal color design to the field of endoscopy.</p></sec><sec sec-type="COI-statement" id="deo2410-sec-0180"><title>CONFLICT OF INTEREST DISCLOSURE</title><p>Tadakazu Hisamatsu has performed Joint Research with Alfresa Pharma Co. Ltd., EA Pharma Co. Ltd. and received grant support from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Daiichi&#x02010;Sankyo, Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., and Mochida Pharmaceutical Co., Ltd., and consulting and lecture fees from EA Pharma Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Nichi&#x02010;Iko Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Mochida Pharmaceutical Co., Ltd., Gilead Sciences, Kissei Pharmaceutical Co. Ltd., and Takeda Pharmaceutical Co. Ltd.</p></sec><sec sec-type="COI-statement" id="deo2410-sec-0190"><p>Jun Miyoshi has received grant support from AbbVie GK, and consulting and lecture fees from EA Pharma Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K.,&#x000a0;Jansen Asia Pacific Pte. Ltd., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co. Ltd., and Takeda Pharmaceutical Co. Ltd.</p></sec><sec sec-type="COI-statement" id="deo2410-sec-0200"><p>Akiko Ohno has received lecture fees and borrowed the equipment necessary for image capture during ESD from Olympus Corporation.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo2410-supitem-0001" position="float" content-type="local-data"><caption><p>FIGURE S1 L*a*b* value data of the blood vessel and the background submucosa under white light imaging and red dichromatic imaging mode in each color vision characteristic.</p><p>L*a*b values of the blood vessel and the background submucosa that were used to calculate the color differences (&#x00394;E00) are presented. (a) Type C group. (b) Type P group. (c) Type D group.</p></caption><media xlink:href="DEO2-5-e410-s001.jpg"/></supplementary-material></sec></body><back><ack id="deo2410-sec-0170"><title>ACKNOWLEDGMENTS</title><p>We thank Edanz (<ext-link xlink:href="https://jp.edanz.com/ac" ext-link-type="uri">https://jp.edanz.com/ac</ext-link>) for editing a draft of this manuscript.</p></ack><ref-list id="deo2410-bibl-0001"><title>REFERENCES</title><ref id="deo2410-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2410-cit-0001">
<string-name>
<surname>Simunovic</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Color vision deficiency</article-title>. <source>Eye</source>
<year>2010</year>; <volume>24</volume>: <fpage>747</fpage>&#x02013;<lpage>755</lpage>.<pub-id pub-id-type="pmid">19927164</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2410-cit-0002">
<string-name>
<surname>Birch</surname>
<given-names>J</given-names>
</string-name>. <article-title>Worldwide prevalence of red&#x02010;green color deficiency</article-title>. <source>J Opt Soc Am A Opt Image Sci Vis</source>
<year>2012</year>; <volume>29</volume>: <fpage>313</fpage>&#x02013;<lpage>320</lpage>.<pub-id pub-id-type="pmid">22472762</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2410-cit-0003">
<string-name>
<surname>Shigeki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tatsuya</surname>
<given-names>O</given-names>
</string-name>. <article-title>Detection and modification of confusing color combinations for red&#x02010;green dichromats to achieve a color universal design</article-title>. <source>Color Res Appl</source>
<year>2008</year>; <volume>33</volume>: <fpage>203</fpage>&#x02013;<lpage>211</lpage>.</mixed-citation></ref><ref id="deo2410-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2410-cit-0004">
<string-name>
<surname>Pramanik</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sherpa</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Shrestha</surname>
<given-names>R</given-names>
</string-name>. <article-title>Color vision deficiency among medical students: An unnoticed problem</article-title>. <source>Nepal Med Coll J</source>
<year>2010</year>; <volume>12</volume>: <fpage>81</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">21222402</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2410-cit-0005">
<string-name>
<surname>Siddiqui</surname>
<given-names>QA</given-names>
</string-name>, <string-name>
<surname>Shaikh</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Qureshi</surname>
<given-names>TZ</given-names>
</string-name>, <string-name>
<surname>Subhan</surname>
<given-names>MM</given-names>
</string-name>. <article-title>A comparison of red&#x02010;green color vision deficiency between medical and non&#x02010;medical students in Pakistan</article-title>. <source>Saudi Med J</source>
<year>2010</year>; <volume>31</volume>: <fpage>895</fpage>&#x02013;<lpage>899</lpage>.<pub-id pub-id-type="pmid">20714688</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2410-cit-0006">
<string-name>
<surname>Koningsberger</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>van Norren</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>van Niel</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Dekker</surname>
<given-names>W</given-names>
</string-name>. <article-title>Does color vision deficiency in the endoscopist influence the accuracy of endoscopic diagnosis? An anonymous study with Dutch gastrointestinal endoscopists</article-title>. <source>Endoscopy</source>
<year>1994</year>; <volume>26</volume>: <fpage>549</fpage>&#x02013;<lpage>553</lpage>.<pub-id pub-id-type="pmid">7828569</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2410-cit-0007">
<string-name>
<surname>Lib&#x000e2;nio</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pimentel&#x02010;Nunes</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bastiaansen</surname>
<given-names>B</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic submucosal dissection techniques and technology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review</article-title>. <source>Endoscopy</source>
<year>2023</year>; <volume>55</volume>: <fpage>361</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">36882090</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2410-cit-0008">
<string-name>
<surname>Ninomiya</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Oka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: A pilot study</article-title>. <source>Therap Adv Gastroenterol</source>
<year>2016</year>; <volume>9</volume>: <fpage>679</fpage>&#x02013;<lpage>683</lpage>.</mixed-citation></ref><ref id="deo2410-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2410-cit-0009">
<string-name>
<surname>Matsuda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ono</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sekiguchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Advances in image enhancement in colonoscopy for detection of adenomas</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>
<year>2017</year>; <volume>14</volume>: <fpage>305</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">28293023</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2410-cit-0010">
<string-name>
<surname>Yahagi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fujimoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Horii</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Dual red imaging: A novel endoscopic imaging technology visualizing thick blood vessels in the gastrointestinal wall</article-title>. <source>Endosc Int Open</source>
<year>2019</year>; <volume>7</volume>: <fpage>E1632</fpage>&#x02013;<lpage>E1635</lpage>.<pub-id pub-id-type="pmid">31788544</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo2410-cit-0011">
<string-name>
<surname>Uraoka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Igarashi</surname>
<given-names>M</given-names>
</string-name>. <article-title>Development and clinical usefulness of a unique red dichromatic imaging technology in gastrointestinal endoscopy: A narrative review</article-title>. <source>Therap Adv Gastroenterol</source>
<year>2022</year>; <volume>15</volume>: <elocation-id>17562848221118302</elocation-id>.</mixed-citation></ref><ref id="deo2410-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo2410-cit-0012">
<string-name>
<surname>Maehata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fujimoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Uraoka</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Efficacy of a new image&#x02010;enhancement technique for achieving hemostasis in endoscopic submucosal dissection</article-title>. <source>Gastrointest Endosc</source>
<year>2020</year>; <volume>92</volume>: <fpage>667</fpage>&#x02013;<lpage>674</lpage>.<pub-id pub-id-type="pmid">32497538</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo2410-cit-0013">
<string-name>
<surname>Oka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iwai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Okuda</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Red dichromatic imaging improves visibility of bleeding during gastric endoscopic submucosal dissection</article-title>. <source>Sci Rep</source>
<year>2023</year>; <volume>13</volume>: <fpage>8560</fpage>.<pub-id pub-id-type="pmid">37237177</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo2410-cit-0014">
<string-name>
<surname>Keene</surname>
<given-names>DR</given-names>
</string-name>. <article-title>A review of color blindness for microscopists: Guidelines and tools for accommodating and coping with color vision deficiency</article-title>. <source>Microsc Microanal</source>
<year>2015</year>; <volume>21</volume>: <fpage>279</fpage>&#x02013;<lpage>289</lpage>.<pub-id pub-id-type="pmid">25739321</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo2410-cit-0015">
<string-name>
<surname>Elfalah</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>AlRyalat</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Yaghi</surname>
<given-names>NE</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>The impact of color vision deficiency on the capability of ophthalmologists to diagnose benign and malignant choroidal tumors</article-title>. <source>J Clin Med</source>
<year>2023</year>; <volume>12</volume>: <fpage>2744</fpage>.<pub-id pub-id-type="pmid">37048826</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo2410-cit-0016">
<string-name>
<surname>Luo</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rigg</surname>
<given-names>B</given-names>
</string-name>. <article-title>The development of the CIE 2000 color&#x02010;difference formula: CIEDE2000</article-title>. <source>Color Res Appl</source>
<year>2001</year>; <volume>26</volume>: <fpage>340</fpage>&#x02013;<lpage>350</lpage>.</mixed-citation></ref><ref id="deo2410-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo2410-cit-0017">
<string-name>
<surname>Thomas</surname>
<given-names>PBM</given-names>
</string-name>, <string-name>
<surname>Nesaratnam</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chaudhuri&#x02010;Vayalambrone</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mollon</surname>
<given-names>JD</given-names>
</string-name>. <article-title>Color vision deficiency among doctors: Can we make useful adaptations to the color codes used in the clinical environment?</article-title>
<source>J Patient Saf</source>
<year>2021</year>; <volume>17</volume>: <fpage>e1646</fpage>&#x02013;<lpage>e1651</lpage>.<pub-id pub-id-type="pmid">31157739</pub-id>
</mixed-citation></ref><ref id="deo2410-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo2410-cit-0018">
<string-name>
<surname>Kumahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamashita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aoki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>T</given-names>
</string-name>. <article-title>Career building for Japanese female hospitalists compared to hospitalists overseas</article-title>. <source>J Hosp Gen Med</source>
<year>2022</year>; <volume>4</volume>: <fpage>279</fpage>&#x02013;<lpage>283</lpage>.</mixed-citation></ref><ref id="deo2410-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo2410-cit-0019">
<string-name>
<surname>Mace</surname>
<given-names>R</given-names>
</string-name>. <article-title>Universal design: Barrier&#x02010;free environment for everyone</article-title>. <source>Designers West</source>
<year>1985</year>; <volume>33</volume>: <fpage>142</fpage>&#x02013;<lpage>152</lpage>.</mixed-citation></ref></ref-list></back></article>